2023
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. Blood. 2023;142(10):887-902.
TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023;15:17588359231152844.
Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Arch Pathol Lab Med. 2023;147(10):1148-1157.
Follicular Dendritic Cell Sarcoma of Uterine Corpus: Report of 2 Cases. Int J Gynecol Pathol. 2023;42(4):390-397.
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood Adv. 2023;7(9):1910-1914.
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Mol Cancer Res. 2023;21(3):253-260.
Proliferating Pilar Tumors Are Characterized by Recurrent 15q, 6q, and 6p22.2 Alterations. Am J Dermatopathol. 2023;45(4):217-226.
A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 2023;12(4):243-250.